UK's different rules for psychedelics versus assisted suicide drugs

Drugs for assisted suicide may bypass standard regulatory processes despite limited evidence.

• Psychedelics face significant barriers to regulation, even though there is promising evidence for their use internationally.
• The current regulatory approach in the UK shows a disparity between assisted suicide drugs and psychedelics.
• There is a call for drugs for assisted suicide to adhere to the same regulatory standards as other medications.
• Rescheduling psychedelics could facilitate further clinical research and exploration of their therapeutic potential.

Simplified